Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: IMMUNOSUPPRESSIVE AGENTS - ADVERSE EFFECTS , . Treffer: 59

2022

Kniepeiss, D; Rosenkranz, AR; Fickert, P; Schemmer, P [Update: Immunosuppression in organ transplantation].
DEUT MED WOCHENSCHR. 2022; 147(18): 1199-1212. Doi: 10.1055/a-1716-8031
Web of Science PubMed FullText FullText_MUG

 

2020

Gauckler, P; Shin, JI; Alberici, F; Audard, V; Bruchfeld, A; Busch, M; Cheung, CK; Crnogorac, M; Delbarba, E; Eller, K; Faguer, S; Galesic, K; Griffin, S; Hrušková, Z; Jeyabalan, A; Karras, A; King, C; Kohli, HS; Maas, R; Mayer, G; Moiseev, S; Muto, M; Odler, B; Pepper, RJ; Quintana, LF; Radhakrishnan, J; Ramachandran, R; Salama, AD; Segelmark, M; Tesař, V; Wetzels, J; Willcocks, L; Windpessl, M; Zand, L; Zonozi, R; Kronbichler, A, ;RITERM, study, group;RITERM, study, group Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Autoimmun Rev. 2020; 19(11):102671 Doi: 10.1016/j.autrev.2020.102671 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Fahrleitner-Pammer, A; Wagner, D; Krisper, P; Amrein, K; Dimai, H Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report.
Osteoporos Int. 2017; 28(3):1149-1152 Doi: 10.1007/s00198-016-3858-2 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Inzinger, M; Wippel-Slupetzky, K; Weger, W; Richter, L; Mlynek, A; Fleischander, B; Scheurecker, C; Sandor, N; Mairhofer, D; Sator, PG; Moser-Oberthaler, S; Häring, N; Viznerova, P; Painsi, C; Tanew, A; Ponholzer, P; Tatarski, R; Brenner, W; Stingl, G; Salmhofer, W; Rappersberger, K; Klein, G; Saxinger, W; Auböck, J; Kölli, C; Trautinger, F; Steiner, A; Ratzinger, G; Strohal, R; Riedl, E; Lange-Asschenfeldt, B; Pehamberger, H; Volc-Platzer, B; Selhofer, S; Legat, FJ; Müllegger, R; Reider, N; Schmuth, M; Hintner, H; Hofer, A; Gruber-Wackernagel, A; Aberer, W; Quehenberger, F; Wolf, P Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria.
Acta Derm Venereol. 2016; 96(2):207-212 Doi: 10.2340/00015555-2214 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Nashan, B; Schemmer, P; Braun, F; Dworak, M; Wimmer, P; Schlitt, H Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial.
Trials. 2015; 16(8):118-118 Doi: 10.1186/s13063-015-0626-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Piros, L; Fehérvári, I; Görög, D; Nemes, B; Szabó, J; Gerlei, Z; Végső, G; Kóbori, L; Máthé, Z Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
Transplant Proc. 2015; 47(7):2201-2206 Doi: 10.1016/j.transproceed.2015.07.026
Web of Science PubMed FullText FullText_MUG

 

Stadlbauer, V Immunosuppression and probiotics: are they effective and safe?
Benef Microbes. 2015; 6(6):823-828 Doi: 10.3920/BM2015.0065
Web of Science PubMed FullText FullText_MUG

 

2014

Alter, M; Satzger, I; Schrem, H; Kaltenborn, A; Kapp, A; Gutzmer, R Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
J Dtsch Dermatol Ges. 2014; 12(6): 480-488. Doi: 10.1111/ddg.12355
Web of Science PubMed FullText FullText_MUG

 

Mehrabi, A; Golriz, M; Adili-Aghdam, F; Hafezi, M; Ashrafi, M; Morath, C; Zeier, M; Hackert, T; Schemmer, P Expanding the indications of pancreas transplantation alone.
Pancreas. 2014; 43(8):1190-1193 Doi: 10.1097/MPA.0000000000000181
Web of Science PubMed FullText FullText_MUG

 

Sterneck, M; Kaiser, GM; Heyne, N; Richter, N; Rauchfuss, F; Pascher, A; Schemmer, P; Fischer, L; Klein, CG; Nadalin, S; Lehner, F; Settmacher, U; Neuhaus, P; Gotthardt, D; Loss, M; Ladenburger, S; Paulus, EM; Mertens, M; Schlitt, HJ Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation.
Am J Transplant. 2014; 14(3):701-710 Doi: 10.1111/ajt.12615 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Arns, W; Sommerer, C; Glander, P; Ariatabar, T; Porstner, M; May, C; Paulus, EM; Shipkova, M; Fischer, W; Liefeldt, L; Hackenberg, R; Schemmer, P; Domhan, S; Zeier, M; Budde, K A randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 year.
Clin Nephrol. 2013; 79(6):421-431 Doi: 10.5414/CN107908
Web of Science PubMed FullText FullText_MUG

 

Eller, K; Kniepeiss, D; Rosenkranz, AR Preoperative risk evaluation: where is the limit for recipients of a pancreatic graft?
Curr Opin Organ Transplant. 2013; 18(1):97-101 Doi: 10.1097/MOT.0b013e32835c9666 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gisondi, P; Cazzaniga, S; Chimenti, S; Giannetti, A; Maccarone, M; Picardo, M; Girolomoni, G; Naldi, L; Psocare Study Group Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry.
J Eur Acad Dermatol Venereol. 2013; 27(1):e30-e41 Doi: 10.1111/j.1468-3083.2012.04450.x
Web of Science PubMed FullText FullText_MUG

 

Kaltenborn, A; Schrem, H Mycophenolate mofetil in liver transplantation: a review.
Ann Transplant. 2013; 18(7): 685-696. Doi: 10.12659/AOT.889299
Web of Science PubMed FullText FullText_MUG

 

Klein, K; Süsal, C; Schäfer, SM; Becker, LE; Beimler, J; Schwenger, V; Zeier, M; Schemmer, P; Macher-Goeppinger, S; Scherer, S; Opelz, G; Morath, C Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.
Atheroscler Suppl. 2013; 14(1):199-202 Doi: 10.1016/j.atherosclerosissup.2012.10.030
Web of Science PubMed FullText FullText_MUG

 

Kniepeiss, D; Wagner, D; Wasler, A; Tscheliessnigg, KH; Renner, W The role of CYP2C8 genotypes in dose requirement and levels of everolimus after heart transplantation.
Wien Klin Wochenschr. 2013; 125(13-14):393-395 Doi: 10.1007/s00508-013-0387-2
Web of Science PubMed FullText FullText_MUG

 

Konieczny, MR; Müller, EJ; Gaggl, A; Bürger, KH Defect coverage with myofasciocutaneous free flaps. Consequence of corticosteroid infiltration of the wrist in a patient on immunosuppressive therapy].
Unfallchirurg. 2013; 116(4):367-370 Doi: 10.1007/s00113-012-2168-1 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Pocivalnik, M; Kirsch, AH; Hassler, EM; Rosenkranz, AR; Eller, K Fever and pneumonitis induced by enteric-coated mycophenolate sodium in a patient after kidney transplantation.
Transpl Int. 2013; 26(7):e54-e57 Doi: 10.1111/tri.12104 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Aringer, M; Burkhardt, H; Burmester, GR; Fischer-Betz, R; Fleck, M; Graninger, W; Hiepe, F; Jacobi, AM; Kötter, I; Lakomek, HJ; Lorenz, HM; Manger, B; Schett, G; Schmidt, RE; Schneider, M; Schulze-Koops, H; Smolen, JS; Specker, C; Stoll, T; Strangfeld, A; Tony, HP; Villiger, PM; Voll, R; Witte, T; Dörner, T Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.
Lupus. 2012; 21(4):386-401 Doi: 10.1177/0961203311426569
Web of Science PubMed FullText FullText_MUG

 

Brandacher, G; Grahammer, J; Sucher, R; Lee, WP Animal models for basic and translational research in reconstructive transplantation.
Birth Defects Res C Embryo Today. 2012; 96(1):39-50 Doi: 10.1002/bdrc.21002
Web of Science PubMed FullText FullText_MUG

 

Strasser, C; Wolf, EM; Kornprat, P; Hermann, J; Münch, A; Langner, C Opportunistic cytomegalovirus infection causing colonic perforation in a patient with systemic lupus erythematosus.
Lupus. 2012; 21(4):449-451 Doi: 10.1177/0961203311425529 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2011

Langner, C; Eherer, AJ; Vieth, M Calcineurin inhibitor therapy-associated esophageal polyps 12 years after heart transplantation.
Endoscopy. 2011; 43 Suppl 2 UCTN(3):E120-E121 Doi: 10.1055/s-0030-1256145 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Piros, L; Máthé, Z; Földes, K; Langer, RM Incisional hernia after simultaneous pancreas kidney tranplantation: a single-center experience from Budapest.
Transplant Proc. 2011; 43(4):1303-1305 Doi: 10.1016/j.transproceed.2011.03.090
Web of Science PubMed FullText FullText_MUG

 

2010

Hoenigl, M; Valentin, T; Salzer, HJ; Zollner-Schwetz, I; Krause, R Underestimating the real burden of invasive fungal infections in hematopoietic stem cell transplant recipients?
Clin Infect Dis. 2010; 51(2): 253-254. Doi: 10.1086/653684 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kniepeiss, D; Wagner, D; Wirnsberger, G; Roller, RE; Wasler, A; Iberer, F; Tscheliessnigg, KH Serum cystatin C is an easy to obtain biomarker for the onset of renal impairment in heart transplant recipients.
J Thorac Cardiovasc Surg. 2010; 140(3):688-693 Doi: 10.1016/j.jtcvs.2010.03.031 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Silbernagel, G; Schmalzing, M; Riessen, R; Koetter, I Sepsis with acral necrosis in a patient with Sharp syndrome - case 8/2010].
Dtsch Med Wochenschr. 2010; 135(36):1741-1741 Doi: 10.1055/s-0030-1247615 (- Case Report)
PubMed FullText FullText_MUG

 

Stary, G; Geusau, A; Greinix, H; Vormittag, L; Stingl, G; Rabitsch, W Epstein-Barr virus-associated oral papulosis in graft-versus-host disease.
Acta Derm Venereol. 2010; 90(5): 542-543. Doi: 10.2340/00015555-0903 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Aringer, M; Houssiau, F; Gordon, C; Graninger, WB; Voll, RE; Rath, E; Steiner, G; Smolen, JS Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
Rheumatology (Oxford). 2009; 48(11):1451-1454 Doi: 10.1093/rheumatology/kep270 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Comi, G; Martinelli, V; Rodegher, M; Moiola, L; Bajenaru, O; Carra, A; Elovaara, I; Fazekas, F; Hartung, HP; Hillert, J; King, J; Komoly, S; Lubetzki, C; Montalban, X; Myhr, KM; Ravnborg, M; Rieckmann, P; Wynn, D; Young, C; Filippi, M Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial.
Lancet. 2009; 374(9700):1503-1511 Doi: 10.1016/S0140-6736(09)61259-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Hochegger, K; Rudnicki, M; Auinger, M; Mark, W; Margreiter, R; Mayer, G; Rosenkranz, AR Fever of unknown origin in renal transplant patients with tacrolimus.
Clin Transplant. 2009; 23(4):575-579 Doi: 10.1111/j.1399-0012.2008.00941.x
Web of Science PubMed FullText FullText_MUG

 

Reinisch, W; Haas, T; Kaser, A; Petritsch, W; Vogelsang, H; Feichtenschlager, T; Novacek, G; Siebert, F; Tilg, H; Knoflach, P Adalimumab for the treatment of Crohn's disease - consensus paper of the Working Group "chronic inflammatory bowel diseases" of the Austrian Society for Gastroenterology and Hepatology].
Z Gastroenterol. 2009; 47(4):372-380 Doi: 10.1055/s-0028-1109218
Web of Science PubMed FullText FullText_MUG

 

2008

Hochegger, K; Jansky, GL; Soleiman, A; Wolf, AM; Tagwerker, A; Seger, C; Griesmacher, A; Mayer, G; Rosenkranz, AR Differential effects of rapamycin in anti-GBM glomerulonephritis.
J Am Soc Nephrol. 2008; 19(8):1520-1529 Doi: 10.1681/ASN.2007121375 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Khalil, M; Enzinger, C; Wallner-Blazek, M; Scarpatetti, M; Barth, A; Horn, S; Reiter, G Epstein-Barr virus encephalitis presenting with a tumor-like lesion in an immunosuppressed transplant recipient.
J Neurovirol. 2008; 14(6):574-578 Doi: 10.1080/13550280802345715 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Wolf, IH; Wolf, P; Cerroni, L; Holzer, H; Kerl, H Drug reactions - new observations.
J Dtsch Dermatol Ges. 2008; 6(6):508-509 Doi: 10.1111/j.1610-0387.2008.06634.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2007

Bonatti, H; Brandacher, G; Boesmueller, C; Cont, M; Hengster, P; Rosenkranz, AR; Krugmann, J; Margreiter, R Hemolytic uremic syndrome following Campath-1H induction.
Transpl Int. 2007; 20(4):386-389 Doi: 10.1111/j.1432-2277.2006.00445.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2006

Hochegger, K; Gruber, J; Lhotta, K Acute inflammatory syndrome induced by mycophenolate mofetil in a patient following kidney transplantation.
Am J Transplant. 2006; 6(4):852-854 Doi: 10.1111/j.1600-6143.2006.01251.x (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schweiger, M; Wasler, A; Prenner, G; Stiegler, P; Stadlbauer, V; Schwarz, M; Tscheliessnigg, K Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients.
Transpl Immunol. 2006; 16(1): 46-51. Doi: 10.1016/j.trim.2006.02.001
Web of Science PubMed FullText FullText_MUG

 

2005

Kneitz, C; Suerbaum, S; Beer, M; Muller, J; Jahns, R; Tony, HP Exacerbation of Whipple's disease associated with infliximab treatment
Scand J Rheumatol. 2005; 34(2):148-151 Doi: 10.1080/03009740510015230 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Schaffellner, S; Jakoby, E; Kniepeiss, D; Stadlbauer, V; Duller, D; Iberer, F; Tscheliessnigg, KH Center experience in liver transplantation (LTX): management of dermal side effects caused by sirolimus.
INT IMMUNOPHARMACOL. 2005; 5(1): 137-140. Doi: 10.1016/j.intimp.2004.09.017
Web of Science PubMed FullText FullText_MUG

 

Vallbracht, II; Popper, HH; Rieber, J; Nowak, F; Gallenberger, S; Piper, B; Helmke, K Lethal pneumonitis under leflunomide therapy.
RHEUMATOLOGY. 2005; 44(12): 1580-1581. Doi: 10.1093/rheumatology/kei076 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2004

Golling, M; Becker, T; Broelsch, C; Candinas, D; Faust, D; Fischer, L; Geissler, E; Graeb, C; Iberer, F; Klupp, J; Kraus, T; Müller, AR; Neuhaus, P; Strassburg, CP; Wolff, M; Zülke, C; Bechstein, WO Consensus-recommendations for sirolimus in liver transplantation.
Z Gastroenterol. 2004; 42(11):1333-1340 Doi: 10.1055/s-2004-813703
Web of Science PubMed FullText FullText_MUG

 

Kniepeiss, D; Iberer, F; Schaffellner, S; Jakoby, E; Duller, D; Tscheliessnigg, Kh Dyslipidemia during sirolimus therapy in patients after liver transplantation.
CLIN TRANSPLANT. 2004; 18(6): 642-646. Doi: 10.1111/j.1399-0012.2004.00253.x
Web of Science PubMed FullText FullText_MUG

 

Reinisch, W; Dejaco, C; Knoflach, P; Petritsch, W; Vogelsang, H; Tilg, H Immunosuppressive therapy for inflammatory bowel disease: consensus by the Austrian working group on IBD.
Z GASTROENTEROL. 2004; 42(9): 1033-1045. Doi: 10.1055/s-2004-813500
Web of Science PubMed FullText FullText_MUG

 

Worm, HC; Wirnsberger, GH; Mauric, A; Holzer, H High prevalence of Chlamydia pneumoniae infection in cyclosporin A-induced post-transplant gingival overgrowth tissue and evidence for the possibility of persistent infection despite short-term treatment with azithromycin.
Nephrol Dial Transplant. 2004; 19(7):1890-1894 Doi: 10.1093/ndt/gfh095 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2003

Ballantyne, CM; Corsini, A; Davidson, MH; Holdaas, H; Jacobson, TA; Leitersdorf, E; März, W; Reckless, JP; Stein, EA Risk for myopathy with statin therapy in high-risk patients.
Arch Intern Med. 2003; 163(5):553-564 Doi: 10.1001/archinte.163.5.553 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Bucher, P; Mathe, Z; Bosco, D; Andres, A; Bühler, LH; Morel, P; Berney, T Islet of Langerhans transplantation for the treatment of type 1 diabetes.
Swiss Surg. 2003; 9(5):242-246 Doi: 10.1024/1023-9332.9.5.242
PubMed FullText FullText_MUG

 

Fahrleitner, A; Prenner, G; Leb, G; Tscheliessnigg, KH; Piswanger-Sölkner, C; Obermayer-Pietsch, B; Portugaller, HR; Berghold, A; Dobnig, H Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation.
Bone. 2003; 32(1):96-106 Doi: 10.1016%2FS8756-3282%2802%2900926-2
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Högenauer, C; Wenzl, HH; Hinterleitner, TA; Petritsch, W Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis.
Aliment Pharmacol Ther. 2003; 18(4):415-423 Doi: 10.1046/j.1365-2036.2003.01662.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kniepeiss, D; Iberer, F; Grasser, B; Schaffellner, S; Tscheliessnigg, KH Sirolimus and mycophenolate mofetil after liver transplantation.
Transpl Int. 2003; 16(7):504-509 Doi: 10.1007/s00147-003-0579-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mangge, H; Gindl, S; Kenzian, H; Schauenstein, K Atopic dermatitis as a side effect of anti-tumor necrosis factor-alpha therapy.
J Rheumatol. 2003; 30(11):2506-2507 (- Case Report)
Web of Science PubMed

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum